These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4408408)

  • 1. [p-butoxyphenylacethydroxamic acid in the treatment of rheumatic diseases].
    Viara M
    Clin Ter; 1974 Jul; 70(2):153-60. PubMed ID: 4408408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and pharmacologic effect of several new hydroxamic acids].
    Papadaki-Valiraki A; Tsatsas G; Varonos D; Delitheos A
    Ann Pharm Fr; 1974 Feb; 32(2):133-8. PubMed ID: 4433114
    [No Abstract]   [Full Text] [Related]  

  • 3. [P-butoxyphenylacethydroxamic acid in analgesic and anti-inflammatory therapy].
    Rosoux E
    Brux Med; 1969 Jul; 49(7):467-9. PubMed ID: 5402954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too].
    Pavelka K; Vojtísek O; Brémová A; Hándlová D; Kanková D; Králová M
    Cas Lek Cesk; 1972; 111(22):514-7. PubMed ID: 5031749
    [No Abstract]   [Full Text] [Related]  

  • 5. [A rapid and objective system of estimation of the anti-inflammatory activity of drugs in humans].
    Franchimont P
    Rev Rhum Mal Osteoartic; 1971 Mar; 38(3):193-9. PubMed ID: 5559717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary study of the action of p-butoxyphenylacethydroxamic acid (Bufexamac) in the treatment of coxarthrosis].
    Bloch-Michel H; Parrot M
    Therapie; 1970; 25(5):969-75. PubMed ID: 5486155
    [No Abstract]   [Full Text] [Related]  

  • 7. [1st considerations on the therapeutic contribution of p-butoxyphenylacethydroxamic acid (Droxaryl) in physical medicine].
    Paque GR
    J Belge Rhumatol Med Phys; 1969; 24(6):273-8. PubMed ID: 5403085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined alclofenac-bufexamac in rheumatology].
    Famaey JP; Bauduin MP; Wanet G
    J Belge Rhumatol Med Phys; 1972; 27(3):110-9. PubMed ID: 4540357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical study of a new non-steroid anti-inflammatory agent: butoxyphenylacethydroxamic acid (Droxaryl)].
    Van Cauwenberge H; Franchimont P
    J Belge Rhumatol Med Phys; 1968; 23(3):133-48. PubMed ID: 5758165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of bufexamac in the treatment of post-partum hemorrhoids following episiotomy].
    Lacheron JM; Schyns PH
    Brux Med; 1974 Apr; 54(4):227-30. PubMed ID: 4429836
    [No Abstract]   [Full Text] [Related]  

  • 11. Bufexamac in the treatment of skin diseases in general practice.
    Valle-Jones JC
    Practitioner; 1974 Sep; 213(1275):383-6. PubMed ID: 4609377
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergy to bufexamac.
    Van Hecke E
    Arch Belg Dermatol; 1973; 29(4):301-3. PubMed ID: 4802391
    [No Abstract]   [Full Text] [Related]  

  • 13. [Droxaryl, a new non-steroid anti-inflammatory agent].
    Suţeanu S
    Med Interna (Bucur); 1969 Jan; 21(1):119-21. PubMed ID: 5305051
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of bufexamac (Droxaryl) ointment and of its excipient on psoriasis cases: double-blind test.
    Van der Meersch J
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):904-8. PubMed ID: 4214665
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of bufexamac for rheumatoid arthritis.
    Rose BS; Isdale IC; Conlon PW
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):150-3. PubMed ID: 4985493
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimentation with Bufexamac in the rheumatologic clinic].
    Dumoulin J; Clauses I
    Rhumatologie; 1970 Nov; 22(9):351-5. PubMed ID: 5313703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statistical evaluation of the therapeutic action of a new anti-rheumatic: 4-isobutyl-phenyl-acetic acid (Ibufenac) in the treatment of rheumatoid arthritis].
    Chériè Lignière G; Colombo B; Carrabba M
    Reumatismo; 1969; 21(3):97-104. PubMed ID: 4929606
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of bufexamac in clinical rheumatology].
    Gabay R; Martin E
    Schweiz Rundsch Med Prax; 1971 Apr; 60(14):445-6. PubMed ID: 5092309
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
    Pavelka K; Wagenhauser F
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):69-72. PubMed ID: 4984321
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationships between structure and four types of pharmacologic activity in arylacetydroxamic acids.
    Lambelin G; Buu-Hoï NP; Brouilhet H; Gautier M; Gillet C; Roba J; Thiriaux J
    Arzneimittelforschung; 1968 Nov; 18(11):1404-8. PubMed ID: 4885157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.